{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:59:10Z","timestamp":1761058750486,"version":"build-2065373602"},"reference-count":61,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Podiatric Medicine and Surgery"],"published-print":{"date-parts":[[2008,1]]},"DOI":"10.1016\/j.cpm.2007.10.003","type":"journal-article","created":{"date-parts":[[2008,1,2]],"date-time":"2008-01-02T17:51:02Z","timestamp":1199296262000},"page":"29-42","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["The Causes of the Charcot Syndrome"],"prefix":"10.1016","volume":"25","author":[{"given":"William","family":"Jeffcoate","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cpm.2007.10.003_bib1","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1016\/S0140-6736(05)67029-8","article-title":"The role of proinflammatory cytokines in the cause of neuropathic osteoarthropathy (acute Charcot foot) in diabetes","volume":"366","author":"Jeffcoate","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.cpm.2007.10.003_bib2","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1359\/jbmr.2001.16.6.1004","article-title":"Expression of osteoprotegerin, receptor activator of NF-kappaB ligand (osteoprotegerin ligand) and related proinflammatory cytokines during fracture healing","volume":"16","author":"Kon","year":"2001","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.cpm.2007.10.003_bib3","doi-asserted-by":"crossref","first-page":"5050","DOI":"10.1210\/endo.142.12.8536","article-title":"Minireview: the OPG\/RANK system","volume":"142","author":"Khosla","year":"2001","journal-title":"Endocrinology"},{"key":"10.1016\/j.cpm.2007.10.003_bib4","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0140-6736(01)05494-0","article-title":"Osteoprotegerin: a link between osteoporosis and arterial calcification?","volume":"358","author":"Hofbauer","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.cpm.2007.10.003_bib5","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature01658","article-title":"Osteoclast differentiation and activation","volume":"423","author":"Boyle","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.cpm.2007.10.003_bib6","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1001\/jama.292.4.490","article-title":"Clinical implications of the osteoprotegerin\/RANKL\/RANK system for bone and vascular diseases","volume":"292","author":"Hofbauer","year":"2004","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.cpm.2007.10.003_bib7","doi-asserted-by":"crossref","first-page":"6323","DOI":"10.1210\/jc.2005-0794","article-title":"Circulating osteoprotegerin and receptor activator for nuclear factor-kappaB ligand: clinical utility in metabolic bone disease assessment","volume":"90","author":"Rogers","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.cpm.2007.10.003_bib8","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1159\/000047893","article-title":"Impaired intramembranous bone formation during bone repair in the absence of tumor necrosis factor-alpha signalling","volume":"169","author":"Gerstenfeld","year":"2001","journal-title":"Cells Tissues Organs"},{"key":"10.1016\/j.cpm.2007.10.003_bib9","first-page":"144","article-title":"Osteoprotegerin and inflammation","volume":"13","author":"Saidenberg-Kermanac'h","year":"2002","journal-title":"Eur Cytokine Netw"},{"key":"10.1016\/j.cpm.2007.10.003_bib10","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1136\/ard.61.suppl_2.ii82","article-title":"Tumour necrosis factor superfamily cytokines and the pathogenesis of inflammatory osteolysis","volume":"61","author":"Lam","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.cpm.2007.10.003_bib11","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1249\/01.MSS.0000142410.45142.28","article-title":"Reductions in basal limb blood flow and lumen diameter after short-term leg casting","volume":"36","author":"Sugawara","year":"2004","journal-title":"Med Sci Sports Exerc"},{"issue":"6","key":"10.1016\/j.cpm.2007.10.003_bib12","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1111\/j.1464-5491.2005.01510.x","article-title":"Calcaneal bone mineral density in patients with Charcot neuropathic osteoarthropathy: differences between Type 1 and Type 2 diabetes","volume":"22","author":"Petrova","year":"2005","journal-title":"Diabet Med"},{"issue":"6","key":"10.1016\/j.cpm.2007.10.003_bib13","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1046\/j.1464-5491.2001.00511.x","article-title":"Calcaneal ultrasonometry in patients with Charcot osteoarthropathy and its relationship with densitometry in the lumbar spine and femoral neck and with markers of bone turnover","volume":"18","author":"Jirkowsk\u00e1","year":"2001","journal-title":"Diabet Med"},{"issue":"3","key":"10.1016\/j.cpm.2007.10.003_bib14","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1093\/ptj\/85.3.249","article-title":"Bone mineral density during total contact cast immobilization for a patient with neuropathic (Charcot) arthropathy","volume":"85","author":"Hastings","year":"2005","journal-title":"Phys Ther"},{"issue":"Suppl 1","key":"10.1016\/j.cpm.2007.10.003_bib15","first-page":"P1116","article-title":"CDUK: a UK-wide, web-based survey of the management of the acute Charcot foot of diabetes","volume":"50","author":"Game","year":"2007","journal-title":"Diabetologia"},{"issue":"8","key":"10.1016\/j.cpm.2007.10.003_bib16","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.2337\/dc06-0306","article-title":"Assessing the outcome of the management of diabetic foot ulcers using ulcer-related and person-related measures","volume":"29","author":"Jeffcoate","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/j.cpm.2007.10.003_bib17","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S1056-8727(97)00080-9","article-title":"Normal blood flow response and vasomotion in the diabetic Charcot foot","volume":"12","author":"Shapiro","year":"1998","journal-title":"J Diabetes Complications"},{"key":"10.1016\/j.cpm.2007.10.003_bib18","doi-asserted-by":"crossref","first-page":"457","DOI":"10.2337\/diabetes.47.3.457","article-title":"Endothelial dysfunction and the expression of endothelial nitric oxide synthetase in diabetic neuropathy, vascular disease, and foot ulceration","volume":"47","author":"Veves","year":"1998","journal-title":"Diabetes"},{"issue":"12","key":"10.1016\/j.cpm.2007.10.003_bib19","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.2337\/dc07-1063","article-title":"Microvascular and C-fiber function in diabetic Charcot neuro-arthropathy and diabetic peripheral neuropathy","volume":"30","author":"Baker","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.cpm.2007.10.003_bib20","first-page":"161","article-title":"Sur quelques arthropathies qui paraiise d\u00e9pendre d'une l\u00e9sion du cerveau ou de la mouelle \u00e9pini\u00e8re","volume":"1","author":"Charcot","year":"1868","journal-title":"Arch Physiol Norm Pathlo"},{"issue":"1","key":"10.1016\/j.cpm.2007.10.003_bib21","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/BF00253862","article-title":"Blood flow in the diabetic neuropathic foot","volume":"22","author":"Edmonds","year":"1982","journal-title":"Diabetologia"},{"key":"10.1016\/j.cpm.2007.10.003_bib22","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/j.1464-5491.1985.tb00683.x","article-title":"Osteopenia and metatarsal fractures in diabetic neuropathy","volume":"2","author":"Cundy","year":"1985","journal-title":"Diabet Med"},{"key":"10.1016\/j.cpm.2007.10.003_bib23","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/1056-8727(94)90058-2","article-title":"Prevalence and magnitude of osteopenia associated with insulin-dependent diabetes mellitus","volume":"8","author":"Kayath","year":"1994","journal-title":"J Diabetes Complications"},{"key":"10.1016\/j.cpm.2007.10.003_bib24","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1111\/j.1464-5491.1995.tb00389.x","article-title":"Peripheral osteopenia in adult patients with insulin-dependent diabetes mellitus","volume":"12","author":"Forst","year":"1995","journal-title":"Diabet Med"},{"key":"10.1016\/j.cpm.2007.10.003_bib25","doi-asserted-by":"crossref","first-page":"827","DOI":"10.2337\/diacare.22.5.827","article-title":"Impact of peripheral neuropathy on bone density in patients with type 1 diabetes","volume":"22","author":"Rix","year":"1999","journal-title":"Diabetes Care"},{"key":"10.1016\/j.cpm.2007.10.003_bib26","first-page":"90","article-title":"Diabetes mellitus and bone metabolism","volume":"26","author":"Ziegler","year":"1992","journal-title":"Horm Metab Res Suppl"},{"issue":"10","key":"10.1016\/j.cpm.2007.10.003_bib27","doi-asserted-by":"crossref","first-page":"3947","DOI":"10.1210\/jc.2006-0711","article-title":"Lower bone mineral content in children with type 1 diabetes mellitus is linked to female sex, low insulin-like growth factor type I levels, and high insulin requirement","volume":"91","author":"L\u00e9ger","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl 1","key":"10.1016\/j.cpm.2007.10.003_bib28","first-page":"260","article-title":"Longitudinal study of vitamin D insufficiency and its association with osteoclastic activity in patients with Charcot osteoarthropathy","volume":"55","author":"Jirkovska","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.cpm.2007.10.003_bib29","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1177\/000331979905001202","article-title":"Medial arterial calcification is frequently found in patients with microalbuminuria","volume":"50","author":"Psyrogiannis","year":"1999","journal-title":"Angiology"},{"key":"10.1016\/j.cpm.2007.10.003_bib30","doi-asserted-by":"crossref","first-page":"303","DOI":"10.2337\/diacare.1.5.303","article-title":"On diabetic osteopathy: a radiographic study of 21 patients","volume":"1","author":"Whitehouse","year":"1978","journal-title":"Diabetes Care"},{"key":"10.1016\/j.cpm.2007.10.003_bib31","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1136\/bmj.284.6320.928","article-title":"Medial arterial calcification and diabetic neuropathy","volume":"284","author":"Edmonds","year":"1982","journal-title":"Br Med J"},{"key":"10.1016\/j.cpm.2007.10.003_bib32","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.0954-6820.1984.tb08740.x","article-title":"Skeletal lesions and arterial calcifications of the feet in diabetics","volume":"687","author":"Lithner","year":"1984","journal-title":"Acta Med Scand Suppl"},{"key":"10.1016\/j.cpm.2007.10.003_bib33","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/BF02581336","article-title":"Medial arterial calcification and diabetic neuropathy","volume":"27","author":"Gentile","year":"1990","journal-title":"Acta Diabetol Lat"},{"key":"10.1016\/j.cpm.2007.10.003_bib34","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/00005792-197205000-00006","article-title":"Neuro-arthropathy (Charcot joints) in diabetes mellitus: a clinical study of 101 cases","volume":"51","author":"Sinha","year":"1972","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.cpm.2007.10.003_bib35","doi-asserted-by":"crossref","first-page":"22","DOI":"10.2214\/ajr.121.1.22","article-title":"Diabetic osteoarthropathy: clinical and roentgenographic observations in 90 cases","volume":"121","author":"Clouse","year":"1974","journal-title":"Am J Roentgenol Radium Ther Nucl Med"},{"key":"10.1016\/j.cpm.2007.10.003_bib36","series-title":"Inflammatory and toxic disorders of bone","first-page":"105","article-title":"Charcot joints","author":"Knaggs","year":"1926"},{"key":"10.1016\/j.cpm.2007.10.003_bib37","doi-asserted-by":"crossref","first-page":"4104","DOI":"10.1210\/jc.2003-031432","article-title":"Localization of osteoprotegerin, tumor necrosis factor-related apoptosis-inducing ligand, and receptor activator of nuclear factor-\u03baB ligand in M\u00f6nckeberg's sclerosis and atherosclerosis","volume":"89","author":"Schoppet","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.cpm.2007.10.003_bib38","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1161\/01.ATV.0000133194.94939.42","article-title":"Vascular calcification","volume":"24","author":"Abedin","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cpm.2007.10.003_bib39","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1161\/01.RES.0000149165.99974.12","article-title":"Regulation of vascular calcification by osteoclast regulatory factors RANKL and osteoprotegerin","volume":"95","author":"Collin-Osdoby","year":"2004","journal-title":"Circ Res"},{"issue":"2","key":"10.1016\/j.cpm.2007.10.003_bib40","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1161\/01.RES.00000175571.53833.6c","article-title":"Bone morphogenetic proteins in vascular calcification","volume":"97","author":"Hruska","year":"2005","journal-title":"Circ Res"},{"issue":"1","key":"10.1016\/j.cpm.2007.10.003_bib41","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1475-2840-4-4","article-title":"Vascular ossification-calcification in metabolic syndrome, type 2 diabetes mellitus, chronic kidney disease, and calciphylaxis-calcific uremic arteriolopathy: the emerging role of sodium thiosulfate","volume":"4","author":"Hayden","year":"2005","journal-title":"Cardiovasc Diabetol"},{"issue":"6","key":"10.1016\/j.cpm.2007.10.003_bib42","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1530\/eje.1.02052","article-title":"Osteoprotegerin serum levels in children with type 1 diabetes: a potential modulating role in bone status","volume":"153","author":"Galluzzi","year":"2005","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"10.1016\/j.cpm.2007.10.003_bib43","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.diabres.2006.09.008","article-title":"Changes of osteoprotegerin before and after insulin therapy in type 1 diabetic patients","volume":"76","author":"Xiang","year":"2007","journal-title":"Diabetes Res Clin Pract"},{"issue":"6","key":"10.1016\/j.cpm.2007.10.003_bib44","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.2353\/ajpath.2006.060398","article-title":"An increased osteoprotegerin serum release characterizes the early onset of diabetes mellitus and may contribute to endothelial cell dysfunction","volume":"169","author":"Secchiero","year":"2006","journal-title":"Am J Pathol"},{"issue":"1","key":"10.1016\/j.cpm.2007.10.003_bib45","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1530\/eje.0.1490039","article-title":"Increased plasma concentrations of osteoprotegerin in type 2 diabetic patients with microvascular complications","volume":"49","author":"Knudsen","year":"2003","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.cpm.2007.10.003_bib46","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.lfs.2004.01.031","article-title":"Effects of antioxidants and nitric oxide on TNF-alpha-induced adhesion molecule expression and NK-kappaB activation in human dermal microvascular endothelial cells","volume":"75","author":"Jiang","year":"2004","journal-title":"Life Sci"},{"key":"10.1016\/j.cpm.2007.10.003_bib47","first-page":"e6","article-title":"Hyperlipidemia promotes osteoclastic potential of bone marrow cells ex vivo","author":"Tintut","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cpm.2007.10.003_bib48","doi-asserted-by":"crossref","first-page":"855","DOI":"10.2337\/diabetes.48.4.855","article-title":"Hyperglycemia-induced activation of the transcription nuclear factor-kappaB in vascular smooth muscle cells","volume":"48","author":"Yerneni","year":"1999","journal-title":"Diabetes"},{"key":"10.1016\/j.cpm.2007.10.003_bib49","doi-asserted-by":"crossref","first-page":"2792","DOI":"10.2337\/diabetes.50.12.2792","article-title":"Diabetes-associated sustained activation of the transcription nuclear factor-kappaB","volume":"50","author":"Bierhaus","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.cpm.2007.10.003_bib50","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/jemt.10119","article-title":"Neuronal regulation of bone metabolism and anabolism: calcitonin gene-related peptide-, substance P-, and tyrosine hydroxylase-containing nerves and the bone","volume":"58","author":"Imai","year":"2002","journal-title":"Microsc Res Tech"},{"issue":"1","key":"10.1016\/j.cpm.2007.10.003_bib51","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.neulet.2004.12.046","article-title":"Inhibitory effect of CGRP on osteoclast formation by mouse bone marrow cells treated with isoproterenol","volume":"379","author":"Ishizuka","year":"2005","journal-title":"Neurosci Lett"},{"issue":"9","key":"10.1016\/j.cpm.2007.10.003_bib52","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1007\/s00125-004-1477-5","article-title":"Vascular calcification and osteolysis in diabetic neuropathy\u2014is RANK-L the missing link?","volume":"47","author":"Jeffcoate","year":"2004","journal-title":"Diabetologia"},{"issue":"2","key":"10.1016\/j.cpm.2007.10.003_bib53","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.diabres.2004.08.006","article-title":"Osteoclastic function is accelerated in male patients with type 2 diabetes mellitus: the preventive role of osteoclastogenesis inhibitory factor\/osteoprotegerin (OCIF\/OPG) on the decrease of bone mineral density","volume":"68","author":"Suzuki","year":"2005","journal-title":"Diabetes Res Clin Pract"},{"issue":"2","key":"10.1016\/j.cpm.2007.10.003_bib54","first-page":"631","article-title":"Associations of serum osteoprotegerin levels with diabetes, stroke, bone density, fractures, and mortality in elderly women","volume":"86","author":"Browner","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.cpm.2007.10.003_bib55","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1210\/jc.2002-020775","article-title":"Increased osteoprotegerin serum levels in men with coronary artery disease","volume":"88","author":"Schoppet","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.cpm.2007.10.003_bib56","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.2337\/diacare.28.9.2176","article-title":"Osteoprotegerin is associated with silent coronary artery disease in high-risk but asymptomatic type 2 diabetic patients","volume":"28","author":"Avignon","year":"2005","journal-title":"Diabetes Care"},{"issue":"9","key":"10.1016\/j.cpm.2007.10.003_bib57","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1016\/j.jacc.2005.12.054","article-title":"The relationship between plasma osteoprotegerin levels and coronary artery calcification in uncomplicated type 2 diabetic subjects","volume":"47","author":"Anand","year":"2006","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.cpm.2007.10.003_bib58","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1530\/eje.1.02049","article-title":"Plasma osteoprotegerin levels are associated with glycaemic status, systolic blood pressure, kidney function and cardiovascular morbidity in type 1 diabetic patients","volume":"154","author":"Rasmussen","year":"2006","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"10.1016\/j.cpm.2007.10.003_bib59","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1042\/CS20050053","article-title":"Genetics of Paget's disease of bone","volume":"109","author":"Daroszewska","year":"2005","journal-title":"Clin Sci"},{"issue":"6","key":"10.1016\/j.cpm.2007.10.003_bib60","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1055\/s-2007-970578","article-title":"Weight-bearing intensity produces Charcot deformity in injured neuropathic feet in diabetes","volume":"115","author":"Kimmerle","year":"2007","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"3","key":"10.1016\/j.cpm.2007.10.003_bib61","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1302\/0301-620X.86B3.14593","article-title":"Pattern of diabetic neuropathic arthropathy associated with the peripheral bone mineral density","volume":"86","author":"Herbst","year":"2004","journal-title":"J Bone Joint Surg"}],"container-title":["Clinics in Podiatric Medicine and Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891842207000869?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891842207000869?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T18:51:23Z","timestamp":1760208683000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0891842207000869"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1]]},"references-count":61,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,1]]}},"alternative-id":["S0891842207000869"],"URL":"https:\/\/doi.org\/10.1016\/j.cpm.2007.10.003","relation":{},"ISSN":["0891-8422"],"issn-type":[{"type":"print","value":"0891-8422"}],"subject":[],"published":{"date-parts":[[2008,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Causes of the Charcot Syndrome","name":"articletitle","label":"Article Title"},{"value":"Clinics in Podiatric Medicine and Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cpm.2007.10.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}